Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1177 of 5804
-
New epilepsy drug vormatrigine tested for Long-Term safety in 700 adults
Disease control ENROLLING_BY_INVITATIONOpen Label Extension Clinical Trial of Vormatrigine in Adult Patients with Epilepsy
Phase: PHASE3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could fasting boost immunotherapy? new trial tests diet combo for lung cancer
Disease control Recruiting nowThe purpose of this study is to learn the effects of fasting on cancer cells while you get maintenance treatment.
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Could a malaria vaccine ward off another deadly disease?
Prevention Recruiting nowThe goal of this observational study is to learn about the impact of malaria vaccination on the risk of invasive non-typhoidal Salmonella disease in children below the age of 5. Eligible participants residing in the Kisantu Health Zone (DRC) and presenting fever are enrolled in h…
Sponsor: International Vaccine Institute • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC
-
AI stethoscope screens thousands of kids for heart disease
Diagnosis CompletedThe goal of this observational diagnostic study is to evaluate whether an artificial intelligence (AI)-enabled smart stethoscope can accurately detect structural heart disease in school-aged children and adolescents (10-18 years) in Ruyang County, China. The main questions it ai…
Sponsor: Heart Health Research Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
New eczema drug shows promise in Mid-Stage trial
Disease control Not yet recruitingThis is a randomized, double-blind, placebo-controlled multicenter clinical study to evaluate the efficacy, safety, and pharmacokinetics of SIM0278 in adult patients (18-75 years) with moderate to severe AD suitable for systemic therapy. Approximately 184 subjects with moderate …
Phase: PHASE2 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can immune therapy help rare muscle disorder?
Disease control Recruiting nowThis is a randomized, placebo-controlled, double blinded phase 2 exploratory clinical trial of intravenously administered pooled human immunoglobulin (IVIG) in anti-3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) immune mediated necrotizing myopathy (IMNM). Planned enrollment is…
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New blood test aims to detect hidden infections in vulnerable patients
Diagnosis Recruiting nowThis clinical trial is designed to evaluate if adding the Karius Spectrum™ plasma test to usual care diagnostic tests, compared to usual care testing alone, among immunocompromised participants presenting with suspected infection in the outpatient setting leads to faster infectio…
Phase: NA • Sponsor: Karius, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
Radioactive drug targets brain tumors in early trial
Disease control Recruiting nowThe researchers are doing this study to find out whether the radiopharmaceutical therapy (RPT) 177Lu-PSMA-617 is a safe treatment for people with IDH wild type glioma.
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New hope for tough lupus cases: experimental therapy UB-VV410 enters human testing
Disease control Recruiting nowThis is an open-label investigator-initiated trial (IIT) to assess the safety, efficacy, and PK(pharmacokinetic)/PD(pharmacodynamics ) of UB-VV410 in adult subjects with clinically active treatment-refractory SLE. The study population will include subjects with active LN (as defi…
Phase: PHASE1 • Sponsor: Nanjing IASO Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Can a second round of radiation save breasts after cancer returns?
Disease control Recruiting nowThe purpose of this research study is to test the safety and possible harms of treating breast cancer with reirradiation, after breast surgery. The researchers want to find out what effects (good and bad) reirradiation has on people who have already received radiation before surg…
Phase: NA • Sponsor: Youssef Zeidan • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can a simple guide after hospital stay curb opioid relapse? philly study aims to find out
Knowledge-focused Recruiting nowPatient Navigation (PN) interventions following hospitalization can improve outcomes for people with opioid use disorder treatment. Delivering PN interventions on a wide scale requires many resources and coordination across institutions. This will use an evidence-based process to…
Phase: NA • Sponsor: Friends Research Institute, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
New drug aims to stop kidney disease relapses
Disease control Recruiting nowThis is a phase II/III multicenter, randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of BAT4406F injection in patients with Minimal Change Disease/Focal Segmental Glomerulosclerosis
Phase: PHASE2, PHASE3 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New therapy targets depression rooted in childhood trauma
Symptom relief Recruiting nowThe RESPOND trial explores the link between early life adversity and later life depressive symptoms. The investigators have designed a new psychological therapy tailored to address the symptoms that can be caused by difficult experiences in early life. These symptoms include low …
Phase: NA • Sponsor: St. Joseph's Healthcare Hamilton • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Can a smartphone app lift depression in young cancer survivors?
Symptom relief Recruiting nowOur team has developed a digital intervention that aims to help adolescent and young adult cancer survivors (AYAs) manage symptoms of depression. This tool includes one psychoeducation component and four components that are based on evidence-based interventions for depression. Th…
Phase: NA • Sponsor: East Carolina University • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Amniotic grafts show promise for chronic wounds in large Real-World study
Disease control OngoingThis retrospective multi-site observational cohort study uses electronic health records (EHR) from U.S. wound care centers to evaluate the effectiveness of four amniotic membrane allografts (Acesso DL, Acesso TL, Neostim DL, Neostim TL) when added to standard wound care for diabe…
Sponsor: Dynamic Medical Services dba Acesso Biologics • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New targeted drug may improve lymphoma treatment
Disease control Recruiting nowThis study aims to explore a new treatment approach for patients with treatment-naive Marginal Zone Lymphoma (MZL). MZL is a type of slow-growing lymphoma that often affects older adults. The current standard treatment involves chemotherapy, but it can have significant side effec…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New adaptive radiation trial aims to hit cancer harder, spare healthy tissue
Disease control Recruiting nowThe goal of this clinical trial is to find out if giving extra adaptive radiation therapy after standard chemoradiation treatment is safe and helpful for people with rectal cancer. The main questions the study aims to answer are: * Can this approach help target the most aggress…
Phase: PHASE1 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New microwave probe aims to zap lung tumors without cutting
Disease control Recruiting nowThe goal of this clinical trial is to learn if the FlexAblate™ Ablation System works to treat a lung cancer nodules and it will also learn about the safety of the ablation system. Participants in this clinical trial will be patients aged over 18 years who have been previously di…
Phase: NA • Sponsor: Endowave Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New pill could ease Post-Surgery pain without opioids
Symptom relief Recruiting nowThis is a phase II/III, multi-center, randomized, double-blind, comparator-controlled study to evaluate the efficacy and safety of HRS-2129 for postoperative pain management in abdominal surgery.
Phase: PHASE2, PHASE3 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
AI spots hidden brain aneurysms in routine scans
Diagnosis OngoingThe goal of this clinical trial is to verify the opportunistic screening potential of the AI software for detection of brain unruptured intracranial aneurysms (UIA) on routinely performed brain NECT scans in a prospective setting in the Belgian population. The main question the …
Phase: NA • Sponsor: Ziekenhuis Oost-Limburg • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC